Showing results (2021-2030 of 2,101) with videos related to
Sort By:
Pageof 211
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2009
Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphomaRichard L Piekarz, Robin Frye, Maria Turner, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2015
Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemiaRichard M Stone, Emanuele Mazzola, Donna Neuberg, et al.Cell Reports|January 17, 2019
Modeling Tumor Phenotypes In Vitro with Three-Dimensional BioprintingEllen M Langer, Brittany L Allen-Petersen, Shelby M King, et al.Critical Care Medicine|June 28, 2011
Validation of a gene expression-based subclassification strategy for pediatric septic shockHector R Wong, Natalie Z Cvijanovich, Geoffrey L Allen, et al.Cancer Discovery|March 7, 2019
A Stromal Lysolipid-Autotaxin Signaling Axis Promotes Pancreatic Tumor ProgressionFrancesca R Auciello, Vinay Bulusu, Chet Oon, et al.Plos One|November 12, 2014
Corticosteroids and pediatric septic shock outcomes: a risk stratified analysisSarah J Atkinson, Natalie Z Cvijanovich, Neal J Thomas, et al.Sensors (Basel, Switzerland)|June 2, 2021
Field-Portable Microplastic Sensing in Aqueous Environments: A Perspective on Emerging TechniquesMorgan G Blevins, Harry L Allen, Beckett C Colson, et al.Blood|June 26, 2023
Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppressionRyan P Jajosky, Kashyap R Patel, Jerry William L Allen, et al.American Journal of Respiratory and Critical Care Medicine|December 10, 2014
Developing a clinically feasible personalized medicine approach to pediatric septic shockHector R Wong, Natalie Z Cvijanovich, Nick Anas, et al.Plos One|March 12, 2014
IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteriaKwan-Ki Hwang, Ashley M Trama, Daniel M Kozink, et al.Pageof 211